Search for: "Com. v. Morris, T." Results 21 - 40 of 46
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Aug 2017, 8:14 pm by Wolfgang Demino
The "Acceptance and Agreement" provision of the contract provided that [t]his Agreement is for FULL SCOPE OF INSURANCE ESTIMATE AND UPGRADES and is subject to insurance company approval. [read post]
22 Jan 2009, 2:06 am
It's something that the California Supreme Court didn't allow in Merrill v. [read post]
24 May 2007, 10:40 am
This isn't the "agency deference" issue that we've discussed recently (see here for that). [read post]
21 Feb 2019, 3:50 am
Nor is there any guidance in the CJEU decision in Huawei v ZTE (ECU:EU:C.2015 - 477) nor in the Guidance issued by the European Commission (CoM [2017] 712 final 29.11.2017). [read post]
12 Mar 2024, 12:46 pm by admin
Feb. 24, 2010) (quoting from Rule 26 report of Martin T. [read post]
16 Sep 2009, 3:30 am
Related posts:Family Guy Wins Court Battle Citing Fair Use In another victory for fair use, Judge Deborah Batts ruled...Interview on Interviewing ITE with Glenn Manishin Glenn Manishin, partner at Duane Morris, tech law guru, and...First Amendment CAN Trump Anonymous Libel After All Ars Technica published a story today exploring a recent Maryland...Palin v. [read post]
27 Mar 2008, 9:26 pm
" In other words, the multi-billion dollar award, when framed as a dollar amount, rather than as a percentage of net wealth, could, after BMW v. [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
30 May 2012, 1:37 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
22 Jun 2011, 7:09 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]